Stratasys SSYS Q1 2026 Earnings EPS Beats Estimates Despite Opaque Revenue Picture Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development NESR Q1 2026 Earnings EPS Beats Estimates by Nearly 20 But Stock Dips Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline Haymaker Acquisition Corp 4 HYAC Q4 2025 Earnings Significant EPS Surprise Driven by Trust Interest Income PSNY Q4 2024 Earnings Massive EPS Miss as Losses Widen Dramatically